The COVID-19 Pandemic and Scientific Community Response in France, Greece, Norway, and Spain

PDF
Published: Dec 31, 2023
DOI: https://doi.org/10.26265/jiim.v8i2.37740
Keywords:
SARS-CoV-2 SARS-CoV-1 influenza cancer cardiovascular bibliometrics
Maxime Medard
Université Grenoble Alpes
Sarah Perraud
Université Grenoble Alpes
Andrea Utrilla Sanchez
Universidad Complutense Madrid
Paula Gonzalez Tornos
Universidad Complutense Madrid
Dilani Yogendran
Oslo Metropolitan University
Artemis Chaleplioglou
Department of Archival, Library & Information Studies, University of West Attica
Abstract

Purpose – COVID-19 pandemic claimed millions of lives and changed everyday life for billions of people worldwide. Europe was severely impacted in health, social and economic aspects. Research efforts reallocation was a necessity to battle against this threat.


Design/methodology/approach – The scientific community responses against COVID-19 were assessed in terms of country paper productivity indexed in PubMed, Scopus, Web of Science, Dimensions and iCite databases. This research project was designed and performed in the framework of Health Information and Libraries Erasmus+ course with the participation of information science students from France, Norway, and Spain.


Findings – Prior to COVID-19 emergence, coronaviruses related publications accounted for approximately 0.15% of the total research output of more than 800,000 reports affiliated to France, Greece, Norway, or Spain. After COVID-19 pandemic the related scientific output was increased by 60-times to a 7% of the total scientific output of more than 900,000 affiliated reports. Between 2020 and 2022, 21,299 COVID-19 publications were affiliated to France, 6897 to Greece, 5353 to Norway, and 29,195 to Spain accounted collectively for approximately 9% of the global scientific output. The coronavirus related publications involved Medicine, Immunology and Microbiology, Biochemistry, Genetics and Molecular Biology but also humanities and social sciences, and economics and business.


Originality/value - COVID-19 spread fast across the globe from Asia to Europe despite quarantines and social distancing measures. International collaborations, space and funding reallocation led to an enormous original research output within months. Lessons from these responses are invaluable in future pandemic preparedness.

Article Details
  • Section
  • Research Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright Notice

Authors who publish with JIIM agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial License that allows others to share the work with:
  2. An acknowledgment of the work's authorship and initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (preferably in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
C. Drosten, S. Gunther, W. Preiser, S. van der Werf, H. R. Brodt, S. Becker, et al., "Identification of a novel coronavirus in patients with severe acute respiratory syndrome," N Engl J Med, vol. 348, pp. 1967-76, May 2003, https://doi.org/10.1056/NEJMoa030747.
T. G. Ksiazek, D. Erdman, C. S. Goldsmith, S. R. Zaki, T. Peret, S. Emery, et al., "A novel coronavirus associated with severe acute respiratory syndrome," N Engl J Med, vol. 348, pp. 1953-66, May 2003, https://doi.org/10.1056/NEJMoa030781.
A. M. Zaki, S. van Boheemen, T. M. Bestebroer, A. D. Osterhaus, and R. A. Fouchier, "Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia," N Engl J Med, vol. 367, pp. 1814-20, November 2012, https://doi.org/10.1056/NEJMoa1211721.
V. da Costa, M. Moreli, and M. Saivish, “The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century,” Archives of virology, vol. 165, no. 7, pp. 1517-1526, April 2020, https://doi.org/10.1007/s00705-020-04628-0.
National Research, C., Policy, A. Global, E. Division on, S. Life, S. Board on Life and A. Committee on Genomics Databases for Bioterrorism Threat, “Seeking Security: Pathogens, Open Access, and Genome Databases,” National Academies Press, 2004, https://doi.org/10.17226/11087.
S. Jiang, L. Lu, and L. Du, “Development of SARS vaccines and therapeutics is still needed,” Future virology, vol. 8, no. 1, pp. 1-2, December 2013, https://doi.org/10.2217/fvl.12.126.
N. Zhu, D. Zhang, W. Wang, X. Li, B. Yang, J. Song, X. Zhao, B. Huang, W. Shi, R. Lu, P. Niu, F. Zhan, X. Ma, D. Wang, W. Xu, G. Wu, G. F. Gao, and W. Tan, "A Novel Coronavirus from Patients with Pneumonia in China, 2019," N Engl J Med, vol. 382, no. 8, pp. 727-733, February 2020, https://doi.org/10.1056/NEJMoa2001017.
R. Powell, L. Rodriquez-Campos, E. Opare-Lokko, B. Ebenso, and M. Allsop, “Flattening’one curve: what about ‘raising the line’on the other? COVID-19 and palliative care in low-income and middle-income countries,” BMJ Supportive & Palliative Care, vol., 11, no. 2, pp. 119-121, July 2021, https://doi.org/10.1136/bmjspcare-2020-002675.
V. J. Clemente-Suárez, A. Hormeño-Holgado, M. Jiménez, J. C. Benitez-Agudelo, E. N.-Jiménez, N. P.-Palencia, R. Maestre-Serrano, C. C. Laborde-Cárdenas, and J. F. Tornero-Aguilera, “Dynamics of population immunity due to the herd effect in the COVID-19 pandemic,” Vaccines, vol. 8, no. 2, p. 236, May 2020, https://doi.org/10.3390/vaccines8020236.
S. Panneer, K. Kantamaneni, R. R. B. Pushparaj, S. Shekhar, L. Bhat, and L. Rice, “Multistakeholder participation in disaster Management—The case of the COVID-19 pandemic,” Healthcare, vol. 9, no. 2, p. 203, February 2021
A. Naqvi, “COVID-19 European regional tracker.” Scientific data, vol. 8, no. 1, pp. 181, July 2021, https://doi.org/10.3390/healthcare9020203.
N. James, M. Menzies, and P. Radchenko, “COVID-19 second wave mortality in Europe and the United States,” Chaos: an interdisciplinary journal of nonlinear science, vol. 31, no. 3, p. 031105, March 2021, https://doi.org/10.1063/5.0041569.
N. Islam, V. M. Shkolnikov, R. J. Acosta, I. Klimkin, I. Kawachi, R. A. Irizarry, et al. “Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries,” BMJ, vol. 373, p. 1137, April 2021, https://doi.org/10.1136/bmj.n1137.
P. Bastard, L. B. Rosen, Q. Zhang, E. Michailidis, H. H. Hoffmann, Y. Zhang, et al. “Autoantibodies against type I IFNs in patients with life-threatening COVID-19,” Science, vol. 370, no. 6515, p. eabd4585, September 2020, https://doi.org/10.1126/science.abd4585.
L. Puślecki, M. Dąbrowski, and M. Puślecki, “Development of innovation cooperation in the time of COVID-19 pandemic,” European research Studies Journal, vol. 24, no. s1, pp. 1049-1073, March 2021, https://doi.org/10.35808/ersj/2087.
L. Charrier, J. Garlasco, R. Thomas, P. Gardois, M. Bo, and C. M. Zotti, “An overview of strategies to improve vaccination compliance before and during the COVID-19 pandemic,” International Journal of Environmental Research and Public Health, vol. 19, no. 17, p. 11044, September 2022, https://doi.org/10.3390/ijerph191711044.
M. D. Jensen, K. Lynggaard, and M. Kluth, “Paths, punctuations and policy learning—Comparing patterns of European use of scientific expertise during the Covid-19 crisis,” Public Organization Review, vol. 22, no. 2, pp. 223-247, May 2022, https://doi.org/10.1007/s11115-022-00634-9.
T. C. Ekundayo, I. R. Orimoloye, O. O. Ololade, and A. I. Okoh, “24 - Prioritization of health emergency research and disaster preparedness: a systematic assessment of the coronavirus disease 2019 pandemic,” in U. Kose, D. Gupta, V. H. C. de Albuquerque, and A. Khanna (Eds), “Data Science for COVID-19,” Academic Press, pp. 465-486, 2022, https://doi.org/10.1016/B978-0-323-90769-9.00033-5.
A. Chaleplioglou and D. Kyriaki-Manessi, "Comparison of Citations Trends between the COVID-19 Pandemic and SARS-CoV, MERS-CoV, Ebola, Zika, Avian and Swine Influenza Epidemics," arXiv preprint arXiv:2006.05366, June 2020, https://doi.org/10.48550/arXiv.2006.05366.
Y. Gong, T. C. Ma, Y. Y. Xu, R. Yang, L. J. Gao, S. H. Wu, et al. Early research on COVID-19: a bibliometric analysis,” The Innovation, vol. 1, no. 2, p. 100027, August 2020, https://doi.org/10.1016/j.xinn.2020.100027.
J. Wang, and N. Hong, “The COVID-19 research landscape: Measuring topics and collaborations using scientific literature,” Medicine (Baltimore), vol. 99, no. 43, p. e22849, Octoobers 2020, https://doi.org/10.1097/MD.0000000000022849.
P. Giannos, K. S. Kechagias, K. Katsikas Triantafyllidis, and M. E. Falagas, “Spotlight on Early COVID-19 Research Productivity: A 1-Year Bibliometric Analysis,” Frontiers in Public Health, vol. 10, p. 811885, May 2022. https://doi.org/10.3389/fpubh.2022.811885.
O. L. Ryosuke, K. Joji, F. Mizuho, and O. Osamu, “COVID-19 as a Research Dynamic Transformer: Emerging Cross-Disciplinary and National Characteristics,” Frontiers in Big Data, vol. 4, p. 631073, July 2021, https://doi.org/10.3389/fdata.2021.631073.
Z. Or, C. Gandré, I. Durand Zaleski, and M. Steffen, “France's response to the Covid-19 pandemic: between a rock and a hard place,” Health Econ Policy Law, vol. 17, no. 1, pp. 14-26, January 2022, https://doi.org/10.1017/S1744133121000165.
J. F. Delfraissy, Y. Yazdanpanah, and Y. Levy, “REACTing: the French response to infectious disease crises,” Lancet, vol. 387, no. 10034, pp. 2183-2185. May 2016, https://doi.org/10.1016/S0140-6736(16)30059-9.
E. Telford, I. Ortega-Perez, G. Mellon, B. Lacarra, E. Adjadj, C. Madelaine, et al. “Chronicles of a pandemic: How France coordinated the scientific research response to COVID-19,” Infect Dis Now, vol. 51, no. 8, pp. 641-646, November 2021, https://doi.org/10.1016/j.idnow.2021.08.003.
A. C. Walls, Y. J. Park, M. A. Tortorici, A. Wall, A. T. McGuire, and D. Veesler, “Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein,” Cell, vol. 181, no. 2, pp. 281-292, April 2020, https://doi.org/10.1016/j.cell.2020.02.058.
P. Gautret, J. C. Lagier, P. Parola, V. T. Hoang, L. Meddeb, M. Mailhe et al, “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial,” International Journal of Antimicrobial Agents, vol. 56, no. 1, p. 105949, July 2020, https://doi.org/10.1016/j.ijantimicag.2020.105949
D. E. Gordon, G. M. Jang, M. Bouhaddou, J. Xu, K. Obernier, K. M. White, M. J. O’Meara, et al, “A SARS-CoV-2 protein interaction map reveals targets for drug repurposing,” Nature, vol. 583, no. 7816, pp. 459–468, July 2020, https://doi.org/10.1038/s41586-020-2286-9.
B. Bikdeli, M. V. Madhavan, D. Jimenez, T. Chuich, I. Dreyfus, E. Driggin et al, “COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review,” Journal of the American College of Cardiology, vol. 75, no. 23, pp. 2950-2973, June 2020, https://doi.org/10.1016/j.jacc.2020.04.031.
J. Grein, N. Ohmagari, D. Shin, G. Diaz, E. Asperges, A. Castagna, et al, “Compassionate use of remdesivir for patients with severe Covid-19,” New England Journal of Medicine, vol. 382, no. 24, pp. 2327-2336, June 2020, https://doi.org/10.1056/NEJMoa2007016.
E. Brocard, P. Melihan-Cheinin, and E. Rusch, “Health democracy in time of COVID-19: a perspective from France,” The Lancet Public Health, vol. 6, no. 4, p. e201, April 2021, https://doi.org/10.1016/S2468-2667(21)00053-0.
L. Atlani-Duault, F. Chauvin, Y. Yazdanpanah, B. Lina, D. Benamouzig, L. Bouadma et al, “France's COVID-19 response: balancing conflicting public health traditions,” The Lancet, vol. 396, no. 10246, pp. 219-221, July 2020, https://doi.org/10.1016/S0140-6736(20)31599-3.
M. Marmot, “COVID-19 in France: challenges and opportunities.” The Lancet, Public Health, vol. 6, no. 4, p. e192, April 2021, https://doi.org/10.1016/S2468-2667(21)00054-2.
P. Zestanakis P, “Cultural responses to the COVID-19 crisis in Greece: The first wave (March–May 2020),” J Eur Stud, vol.53, no. 1, pp. 70-84, March 2023, https://doi.org/10.1177/00472441221141957.
T. Kousi, L. C. Mitsi, and J. Simos, “The Early Stage of COVID-19 Outbreak in Greece: A Review of the National Response and the Socioeconomic Impact,” Int J Environ Res Public Health, vol. 18, no. 1, p. 322, January 2021, https://doi.org/10.3390/ijerph18010322.
S. Tsiodras, “COVID-19 research and science in the service of public health: the example of Greece,” Nat Immunol, vol. 22, pp. 531–532, April 2021, https://doi.org/10.1038/s41590-021-00919-z.
E. Anastasiou, and M. N. Duquenne, “First-Wave COVID-19 Pandemic in Greece: The Role of Demographic, Social, and Geographical Factors in Life Satisfaction during Lockdown,” Social Sciences, vol. 10, no. 6, p. 186, May 2021, https://doi.org/10.3390/socsci10060186.
M. Melidis, and S. I. Tzagkarakis, “The evolution of social vulnerability in Greece during the economic crisis (2008-2017),” European Societies, vol. 24, no. 2, pp. 229-250, December 2021, https://doi.org/10.1080/14616696.2021.2007973.
L. M. Helsingen, E. Refsum, D. K. Gjøstein, M. Loberg, M. Bretthauer, M. Kalager, and L. Emilsson, “The COVID-19 pandemic in Norway and Sweden – threats, trust, and impact on daily life: a comparative survey,” BMC Public Health, vol. 20, p. 1597, October 2020, https://doi.org/10.1186/s12889-020-09615-3.
G. Ursin, I. Skjesol, and J. Tritter, “The COVID-19 pandemic in Norway: The dominance of social implications in framing the policy response,” Health Policy and Technology, vol. 9, no. 4, pp. 663-672, December 2020, https://doi.org/10.1016/j.hlpt.2020.08.004.
I. Skjesol, G. Ursin, and J. Tritter, “Learning to live with COVID-19 in Norway: Moving from a pandemic to an endemic state,” Health Policy and Technology, p. 100815, October 2023, https://doi.org/10.1016/j.hlpt.2023.100815.
T. Christensen, and P. Lægreid, “Balancing Governance Capacity and Legitimacy: How the Norwegian Government Handled the COVID-19 Crisis as a High Performer,” Public Adm Rev, vol. 80, no. 5, pp. 774-779, September 2020, https://doi.org/10.1111/puar.13241.
S. Royo, “Responding to COVID-19: The Case of Spain,” Eur Policy Anal, vol. 6, no. 2, pp. 180-190, December 2020, https://doi.org/10.1002/epa2.1099.
M. Rodriguez-Arrastia, M. García-Martín, A. Romero-López, C. Ropero-Padilla, C. Ruiz-Gonzalez, P. Roman, and N. Sanchez-Labraca, “Evolution of the Public-Health Response to COVID-19 Pandemic in Spain: A Descriptive Qualitative Study,” Int J Environ Res Public Health, vol. 19, no. 7, p. 3824, March 2022, https://doi.org/10.3390/ijerph19073824.
O. Millet, A. L. Cortajarena, X. Salvatella, L. L. Kiessling, and J. Jiménez-Barbero, “Scientific response to the coronavirus crisis in Spain: collaboration and multidisciplinarity,” ACS Chemical Biology, vol. 15, no. 7, pp. 1722-1723, July 2020, https://doi.org/10.1021/acschembio.0c00496.
A. García-Basteiro, C. Alvarez-Dardet, A. Arenas, R. Bengoa, C. Borrell, M. Del Val, et al, “The need for an independent evaluation of the COVID-19 response in Spain,” The Lancet, vol. 396, no. 10250, pp. 529-530, August 2020, https://doi.org/10.1016/S0140-6736(20)31713-X.
E. Garcia-Garzon, A. Angulo-Brunet, O. Lecuona, J. R. Barrada, amd G. Corradi, “Exploring COVID-19 research credibility among Spanish scientists,” Curr Psychol, vol. 28, pp. 1-12, February 2022, https://doi.org/10.1007/s12144-022-02797-6. https://doi.org/10.1007/s12144-022-02797-6.
J. D. Sachs, S. S. A. Karim, L. Aknin, J. Allen, K. Brosbøl, F. Colombo et al. “The Lancet Commission on lessons for the future from the COVID-19 pandemic,” The Lancet, vol. 400, no. 10359, pp. 1224-1280, October 2022, https://doi.org/10.1016/S0140-6736(22)01585-9.
S. H. LoGiudice, A. Liebhaber, and H. Schöder, “Overcoming the COVID-19 Crisis and Planning for the Future,” J Nucl Med, vol. 61, no. 8, pp. 1096-1101, August 2020, https://doi.org/10.2967/jnumed.120.250522.
O. A. Adegboye, A. I. Adekunle, A. Pak, E. Gayawan, D. H. Leung, D. P. Rojas, D. P., et al, “Change in outbreak epicentre and its impact on the importation risks of COVID-19 progression: A modelling study,” Travel Medicine and Infectious Disease, vol. 40, p. 101988. March-April 2021, https://doi.org/10.1016/j.tmaid.2021.101988.
J. Winkelmann, E. Webb, G. A. Williams, C. Hernández-Quevedo, C. B. Maier, and D. Panteli, “European countries' responses in ensuring sufficient physical infrastructure and workforce capacity during the first COVID-19 wave,” Health Policy, vol. 126, no. 5, pp. 362-372, May 2022, https://doi.org/10.1016/j.healthpol.2021.06.015.